Pyrazole derivatives as 5-LO inhibitors

Details for Australian Patent Application No. 2008331199 (hide)

Owner Pfizer Inc.

Inventors Woodard, Scott Santford; Grapperhaus, Margaret Lanahan; Graneto, Matthew J; Tollefson, Michael Brent; Alvira, Edgardo; Maddux, Todd Michael; Vonder Embse, Richard Alan; Seidel, Ronald Edward; Schmidt, Michelle Ann; Sample, Ray Kirby; Iyanar, Kaliappan; Mahoney, Matthew William; Wagner, Grace Mary; Selbo, Jon Gordon; Massa, Mark Alan

Agent Shelston IP

Pub. Number AU-A-2008331199

PCT Pub. Number WO2009/069044

Priority 61/004,236 26.11.07 US; 61/055,497 23.05.08 US; 61/004,261 26.11.07 US

Filing date 20 November 2008

Wipo publication date 4 June 2009

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/069044 Priority application(s): WO2009/069044

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008331230-Barrier

2008331187-Novel glucocorticoid receptor agonists